National Institute for Health and Care Excellence

Capital Southwest Announces Financial Results for Second Fiscal Quarter Ended September 30, 2023 and Announces Increase in Total Dividends to $0.63 per share for the Quarter Ended December 31, 2023

Retrieved on: 
Monday, October 30, 2023
Line of credit, Treasury, SOFR, Equity, National Institute for Health and Care Excellence, Exercise, PTSD, Small Business Administration, Deutsche Bank, NAV, Primary Dealer Credit Facility, Share repurchase, Acquisition, Engineering, Small business, Credit, Safety, Investment, Patient, Revenue recognition, Debenture, SBIC, Note, Growth, Pharmacy, External commercial borrowing, Depression, State Board of Administration of Florida, SBA, UTI, Chronic pain, I-45, Credit Accumulation and Transfer Scheme, Common, Renewable energy, Bank, Security (finance), Holding company

For the quarter ended September 30, 2023, Capital Southwest reported total investment income of $42.8 million, compared to $40.4 million in the prior quarter.

Key Points: 
  • For the quarter ended September 30, 2023, Capital Southwest reported total investment income of $42.8 million, compared to $40.4 million in the prior quarter.
  • For the quarter ended September 30, 2023, total operating expenses (excluding interest expense) were $5.9 million, compared to $5.7 million in the prior quarter.
  • For the quarter ended September 30, 2023, interest expense was $10.5 million as compared to $9.7 million in the prior quarter.
  • For the quarter ended September 30, 2023, total pre-tax net investment income was $26.4 million, compared to $25.0 million in the prior quarter.

Accarent Health's Commitment: Ensuring Equal Access to Premium Cardiovascular Care

Retrieved on: 
Thursday, October 19, 2023
Angiography, Angioplasty, Najib Roger Accar, Certification, Percutaneous coronary intervention, Transport, Myocardial infarction, Risk, Hypertension, Aortic stenosis, Hospital, National Institute for Health and Care Excellence, Patient, Death, Cardiac catheterization, Pharmaceutical industry, Nursing, MD, Health

They also are less likely than non-minority patients to receive potentially beneficial treatments such as angiography or percutaneous coronary intervention.

Key Points: 
  • They also are less likely than non-minority patients to receive potentially beneficial treatments such as angiography or percutaneous coronary intervention.
  • In addition to improved awareness and better control of hypertension in minority populations, improved access to appropriate intervention is important to addressing these disparities.
  • Accarent Health is a unified technology and care management platform granting access to pre-negotiated, fixed bundled prices for complex medical procedures and treatments, eliminating unpredictable costs and providing increased access to quality care.
  • For more information or to access these or other cardiovascular treatment options visit Accarent Health at www.accarenthealth.com.

Latticework Capital Management Announces Partnership with Institutes of Health, a Leading Medical Provider of Advanced Treatment Programs

Retrieved on: 
Monday, October 23, 2023
Finance, Telemedicine, Virtual Medicine, Business, Professional Services, Biotechnology, Other Health, Managed Care, Health, General Health, IOH, Growth, Rockefeller Capital Management, Patient, Partnership, Entrepreneurship, National Institute for Health and Care Excellence, Pharmaceutical industry, Hospital

Latticework Capital Management, a Dallas-based private equity firm focused on partnering with entrepreneurially-minded management teams to build leading healthcare companies, today announced a strategic investment in Institutes of Health, LLC (“IOH”), a leading multi-disciplinary workers’ compensation treatment provider focused on patients suffering from complex and chronic conditions.

Key Points: 
  • Latticework Capital Management, a Dallas-based private equity firm focused on partnering with entrepreneurially-minded management teams to build leading healthcare companies, today announced a strategic investment in Institutes of Health, LLC (“IOH”), a leading multi-disciplinary workers’ compensation treatment provider focused on patients suffering from complex and chronic conditions.
  • Headquartered in San Diego, California, IOH provides high quality, efficient and patient-centered care resulting in optimal clinical outcomes for patients while driving substantial cost savings within the healthcare system.
  • “Latticework is highly impressed with the deep commitment the senior leadership team and the entire Institutes of Health staff have in their mission of enriching patient lives through thoughtful treatment and outstanding clinical results,” said Steve Neumann, Latticework Managing Partner.
  • “We are thrilled to be partnering with the entire IOH team as the Company expands these services across its current geographic footprint and beyond.”

BRUKINSA® Receives Positive Recommendation from NICE in U.K. for Adult Patients with Chronic Lymphocytic Leukemia

Retrieved on: 
Friday, October 20, 2023
Biotechnology, Pharmaceutical, Health, Oncology, National Institute for Health and Care Excellence, SSE, United Kingdom, BGNE, BR, Leeds Teaching Hospitals NHS Trust, TP53, NICE, FCR, NHS, Disease, Leukemia, Healthcare Improvement Scotland, FDG, BTK, Patient, SEQUOIA, Pharmaceutical industry, CLL, EU, BeiGene

“This follows the previous approval of BRUKINSA by NICE in July 2022 as the only cost-effective treatment for patients with Waldenstrom’s macroglobulinemia.

Key Points: 
  • “This follows the previous approval of BRUKINSA by NICE in July 2022 as the only cost-effective treatment for patients with Waldenstrom’s macroglobulinemia.
  • “This decision represents a significant milestone for patients in England and Wales with CLL, the most common form of leukemia in adults,” said Nick York, Patient Advocacy Healthcare Liaison Officer, U.K. Leukemia Care.
  • “Despite continued treatment advances, many patients with CLL will relapse and need additional treatment options.
  • Furthermore, a proportion of patients have a disease which is refractory to initial treatment.”
    BRUKINSA is the third BTKi for CLL to be recommended by NICE for routine commissioning.

The National Institute for Health and Care Excellence Endorses Aquablation® Therapy with "Standard Arrangements" Recommendation

Retrieved on: 
Thursday, October 12, 2023
Health, BPH, United Kingdom, Standard of care, Frimley Health NHS Foundation Trust, Safety, Urology, SAN, NICE, National Institute for Health and Care Excellence, Pharmaceutical industry, Aquablation therapy

NICE plays a pivotal role in providing guidance to enhance health and social care in the United Kingdom.

Key Points: 
  • NICE plays a pivotal role in providing guidance to enhance health and social care in the United Kingdom.
  • For a procedure to secure such a recommendation, it must demonstrate both short-term and long-term safety and efficacy.
  • NICE’s endorsement underscores that the robotically assisted Aquablation therapy meets these rigorous standards.
  • This bolsters our conviction that Aquablation therapy is on course to be the global standard of care for BPH."

Fast, Faster, Fastest: Is It Time for Automated Model Building? Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Monday, October 16, 2023
Doctor of Philosophy, Python, Microsoft Excel, Automation, Thermo Fisher Scientific, Communication, MDCM, FACP, National Institute for Health and Care Excellence, PPD, EDT, HTA, NICE, DICE, FRCPC, Management, Medical device

TORONTO, Oct. 16, 2023 /PRNewswire-PRWeb/ -- Health economic models are now used in every stage of product development, from early planning and portfolio selection based on target product profiles; through analyses to understand which gaps in the evidence have the biggest impact on predicted value; to health technology assessment (HTA) submissions, budget impact estimates and price negotiations. To facilitate quicker development of models, whole disease models that can be reused have been proposed. The National Institute for Health and Care Excellence (NICE) in the UK is piloting the pathway assessment framework where HTA will be supported by an open-source model available to all stakeholders. This will also help ensure consistency across decisions that previously were hard to consolidate across single technology appraisals.

Key Points: 
  • The featured speakers will discuss how automation tools can leverage the power of server-based installations while preserving the Excel-based nature of models preferred by stakeholders.
  • To facilitate quicker development of models, whole disease models that can be reused have been proposed.
  • This will also help ensure consistency across decisions that previously were hard to consolidate across single technology appraisals.
  • Remaining challenges regarding training of model builders and users, and making such models submission ready will be discussed by the panelists.

How to Lose Weight Fast and Improve Your Mental Health at Gowalking.com

Retrieved on: 
Tuesday, October 3, 2023
Exercise, Drudge Report, Travel, Mayo Clinic, Depression, Diabetes, Friends, American Heart Association, Osteoporosis, WebMD, Anxiety, Stroke, American Psychological Association, Weight loss, BOCA, Multimedia, Dementia, Walking, Risk, Cancer, Clinical professor, Health, Mental health, News, Memory, National Institute for Health and Care Excellence, Nursing, Residential care, Dietary supplement

Here, you can stay updated with the latest walking news articles that delve into the numerous fitness and mental health benefits of walking.

Key Points: 
  • Here, you can stay updated with the latest walking news articles that delve into the numerous fitness and mental health benefits of walking.
  • Articles cover topics such as walking workouts, walking for exercise, walking for health, and exercise walking for fitness and fun.
  • Discover articles discussing how walking can trim your waistline, improve your heart health, and aid in weight loss.
  • Walking offers a multitude of physical and mental health benefits:
    Reduced risk of serious illnesses like heart disease, stroke, diabetes, and certain cancers.

How to Lose Weight Fast and Improve Your Mental Health at Gowalking.com

Retrieved on: 
Tuesday, October 3, 2023
Exercise, Drudge Report, Travel, Mayo Clinic, Depression, Diabetes, Friends, American Heart Association, Osteoporosis, WebMD, Anxiety, Stroke, American Psychological Association, Weight loss, BOCA, Dementia, Walking, Risk, Cancer, Clinical professor, Health, Mental health, News, Memory, National Institute for Health and Care Excellence, Residential care, Dietary supplement

Here, you can stay updated with the latest walking news articles that delve into the numerous fitness and mental health benefits of walking.

Key Points: 
  • Here, you can stay updated with the latest walking news articles that delve into the numerous fitness and mental health benefits of walking.
  • Articles cover topics such as walking workouts, walking for exercise, walking for health, and exercise walking for fitness and fun.
  • Discover articles discussing how walking can trim your waistline, improve your heart health, and aid in weight loss.
  • Join walking clubs near you, find walking clubs wherever you travel, find friends, stay informed with the latest fitness walking news, and start your journey to improved health and mental well-being.

AliveCor's KardiaMobile® 6L Becomes First Personal ECG Device Recommended for Use in Psychiatric Services in England and Wales

Retrieved on: 
Tuesday, September 26, 2023
Criticism of the National Health Service (England), Travel, Diuretic, National Health Service, Intersex, Anxiety, Electricity, Business, ECG, QT, Tees, Esk and Wear Valleys NHS Foundation Trust, EVA, Psychiatrist, QT interval, Patient, Collection, Physician, National Institute for Health and Care Excellence, NHS, Cardiology, NICE, Hospital, Pharmaceutical industry, Medical imaging, Birth control, Alivecor

1, 2 KardiaMobile 6L is a portable ECG recording device that provides instant detection of cardiac abnormalities and can be used to measure heart changes including cardiac QT interval.1

Key Points: 
  • 1, 2 KardiaMobile 6L is a portable ECG recording device that provides instant detection of cardiac abnormalities and can be used to measure heart changes including cardiac QT interval.1
    "Timely ECG monitoring of patients who are on antipsychotic medication can save lives.
  • Having access to KardiaMobile 6L will mean potentially vulnerable patients can now be seen in the comfort of their homes, reducing their stress whilst ensuring that this essential monitoring is completed anywhere, at any time.
  • KardiaMobile 6L has been recommended as part of NICE's EVA pilot project, created to drive earlier access to promising healthcare innovations for use within the National Health Service in England and Wales.
  • "We have a wealth of clinical data on the use of KardiaMobile 6L in cardiology, with NICE's EVA recommendation we will now support the collection of real-world evidence as to its effectiveness in psychiatric services.

Eye Care Organizations Unite to Save Sight of Premature Infants Using Artificial Intelligence

Retrieved on: 
Thursday, September 21, 2023
Retina, Telehealth, Partnership, National Eye, Life, DL, Oregon Health & Science University, Oxygen, Ophthalmology, Research, Paratriathlon, Eye, Patient, Premature, Orbis International, Risk, Child, SUNY Downstate Health Sciences University, ROP, Artificial intelligence, Diagnosis, National Eye Institute, FDA, National Institute for Health and Care Excellence, Disease, Pharmaceutical industry, Nursing, Birth control, Medical device, Orbis, AI

NEW YORK, Sept. 21, 2023 /PRNewswire/ -- Eye care nonprofit Orbis International is excited to announce a new strategic partnership with Siloam Vision to use the company's cloud-based telemedicine platform to expand access to eye care and prevent blindness in premature infants living in hard-to-reach communities. Siloam Vision's artificial intelligence (AI) platform helps diagnose retinopathy of prematurity (ROP) – the leading cause of childhood blindness globally.

Key Points: 
  • Siloam Vision's artificial intelligence (AI) platform helps diagnose retinopathy of prematurity (ROP) – the leading cause of childhood blindness globally.
  • Orbis and Siloam Vision have aligned missions to make sure no child starts out life blind from an avoidable cause.
  • We are excited to partner with Orbis to help save the sight of more preterm babies in hard-to-reach-communities."
  • Orbis is working to ensure eye care professionals everywhere can access these tools for free.